Targeting mitotic exit with hyperthermia or APC/C inhibition to increase paclitaxel efficacy
Cell Cycle2013Vol. 12(16), pp. 2598–2607
Citations Over TimeTop 19% of 2013 papers
Abstract
Microtubule-poisoning drugs, such as Paclitaxel (or Taxol, PTX), are powerful and commonly used anti-neoplastic agents for the treatment of several malignancies. PTX triggers cell death, mainly through a mitotic arrest following the activation of the spindle assembly checkpoint (SAC). Cells treated with PTX slowly slip from this mitotic block and die by mitotic catastrophe. However, cancer cells can acquire or are intrinsically resistant to this drug, posing one of the main obstacles for PTX clinical effectiveness. In order to override PTX resistance and increase its efficacy, we investigated both the enhancement of mitotic slippage and the block of mitotic exit.
Related Papers
- → The Aurora kinase inhibitor ZM447439 accelerates first meiosis in mouse oocytes by overriding the spindle assembly checkpoint(2010)63 cited
- → The Spindle Checkpoint in the Dinoflagellate Crypthecodinium cohnii(2000)26 cited
- [Antimicrotubule agents can activate different apoptotic pathways].(2007)
- Investigation into how mitotic spindle checkpoint function is compromised by SV40 large T antigen.(2005)
- → Abstract 4952: Persistent expression of Nqo1 by p62-mediated Nrf2 activation facilitates p53-dependent mitotic catastrophe(2012)